{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:38:14Z","timestamp":1780396694116,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bill and Melinda Gates Foundation (BMGF) through the VALIDATE Network."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Post-Kala-Azar Dermal Leishmaniasis (PKDL) Consortium convened its seventh meeting from 28 to 29 November 2024 in Kolkata, India, to advance research and public health strategies related to PKDL and visceral leishmaniasis. This report summarizes the key discussions and outcomes of the meeting and proposes a way forward for addressing the last-mile challenge of eliminating leishmaniasis as a public health problem in South Asia and subsequently East Africa.<\/jats:p>","DOI":"10.1186\/s13071-025-07175-2","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:08:19Z","timestamp":1773767299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Report of the Seventh Post-Kala-Azar Dermal Leishmaniasis Consortium meeting, Kolkata, India, 28\u201329 November 2024"],"prefix":"10.1186","volume":"19","author":[{"given":"Mitali","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritika","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristien","family":"Cloots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard E.","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"7175_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1756-3305-6-196","volume":"6","author":"P Desjeux","year":"2013","unstructured":"Desjeux P, Ghosh RS, Dhalaria P, Strub-Wourgaft N, Zijlstra EE. Report of the Post Kla-Azar Dermal Leishmaniasis (PKDL) Consortium meeting, New Delhi, India, 27\u201329 June 2012. Parasit Vectors. 2013;6:196.","journal-title":"Parasit Vectors"},{"key":"7175_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13071-020-04011-7","volume":"13","author":"EE Zijlstra","year":"2020","unstructured":"Zijlstra EE, Kumar A, Sharma A, Rijal S, Mondal D, Routray S. Report of the fifth Post Kala-Azar Dermal Leishmaniasis (PKDL) Consortium meeting, Colombo, Sri Lanka, 14\u201316 May 2018. Parasit Vectors. 2020;13:159.","journal-title":"Parasit Vectors"},{"key":"7175_CR3","first-page":"125","volume":"57","author":"UN Brahmachari","year":"1922","unstructured":"Brahmachari UN. A new form of cutaneous leishmaniasis-dermal leishmanoid. Ind Med Gaz. 1922;57:125\u20137.","journal-title":"Ind Med Gaz"},{"key":"7175_CR4","first-page":"406","volume":"63","author":"UN Brahmachari","year":"1928","unstructured":"Brahmachari UN. A treatise on Kala-Azar. Indian Med Gaz. 1928;63:406\u20137.","journal-title":"Indian Med Gaz"},{"key":"7175_CR5","first-page":"393","volume":"89","author":"UN Brahmachari","year":"1989","unstructured":"Brahmachari UN. Chemotherapy of antimonial compounds in kala-azar infection. Part IV. Further observations on the therapeutic values of urea stibamine. By U.N. Brahmachari, 1922. Indian J Med Res. 1989;89:393\u2013404.","journal-title":"Indian J Med Res"},{"key":"7175_CR6","first-page":"492","volume":"89","author":"UN Brahmachari","year":"1989","unstructured":"Brahmachari UN. Chemotherapy of antimonial compounds in kala-azar infection. Part I. By U. N. Brahmachari, 1922. Indian J Med Res. 1989;89:492\u2013522.","journal-title":"Indian J Med Res"},{"key":"7175_CR7","unstructured":"WHO. Ending the neglect to attain the sustainable development goals: a road map for neglected tropical diseases 2021\u20132030. Geneva: WHO; 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240010352. Accessed 1 Nov 2024."},{"key":"7175_CR8","doi-asserted-by":"publisher","unstructured":"Ghosh D, Sagar SK, Uddin MR, Rashid MU, Maruf S, Nath R, et al. Post\nkala-azar dermal leishmaniasis burden at the village level in selected high\nvisceral leishmaniasis endemic upazilas in Bangladesh. Int J Infect Dis. 2024;147:107213. https:\/\/doi.org\/10.1016\/j.ijid.2024.107213.","DOI":"10.1016\/j.ijid.2024.107213"},{"key":"7175_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1046\/j.1365-2133.2000.03603.x","volume":"143","author":"EE Zijlstra","year":"2000","unstructured":"Zijlstra EE, Khalil EA, Kager PA, El-Hassan AM. Post kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis. Br J Dermatol. 2000;143:136\u201343. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03603.x.","journal-title":"Br J Dermatol"},{"key":"7175_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007653","volume":"13","author":"D Mondal","year":"2019","unstructured":"Mondal D, Kumar A, Sharma A, Ahmed MM, Hasnain MG, Alim A, et al. Relationship between treatment regimens for visceral leishmaniasis and development of postkala-azar dermal leishmaniasis and visceral leishmaniasis relapse: a cohort study from Bangladesh. PLoS Negl Trop Dis. 2019;13:e0007653. https:\/\/doi.org\/10.1371\/journal.pntd.0007653.","journal-title":"PLoS Negl Trop Dis"},{"key":"7175_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008429","volume":"14","author":"V Goyal","year":"2020","unstructured":"Goyal V, Das VNR, Singh SN, Singh RS, Pandey K, Verma N, et al. Long-term incidence of relapse and postkala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India. PLoS Negl Trop Dis. 2020;14:e0008429. https:\/\/doi.org\/10.1371\/journal.pntd.0008429.","journal-title":"PLoS Negl Trop Dis"},{"key":"7175_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.1365-3156.2002.00832.x","volume":"7","author":"EA Khalil","year":"2002","unstructured":"Khalil EA, Zijlstra EE, Kager PA, El Hassan AM. Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan. Trop Med Int Health. 2002;7:35\u201344. https:\/\/doi.org\/10.1046\/j.1365-3156.2002.00832.x.","journal-title":"Trop Med Int Health"},{"key":"7175_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1046\/j.1365-2249.1998.00468.x","volume":"111","author":"S Gasim","year":"1998","unstructured":"Gasim S, Elhassan AM, Khalil EA, Ismail A, Kadaru AM, Kharazmi A, et al. High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of postkala-azar dermal leishmaniasis. Clin Exp Immunol. 1998;111:64\u20139. https:\/\/doi.org\/10.1046\/j.1365-2249.1998.00468.x.","journal-title":"Clin Exp Immunol"},{"key":"7175_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/352934","volume":"2015","author":"M Holcar","year":"2015","unstructured":"Holcar M, Goropevsek A, Ihan A, Avcin T. Age-related differences in percentages of regulatory and effector T lymphocytes and their subsets in healthy individuals and characteristic STAT1\/STAT5 signaling response in helper T lymphocytes. J Immunol Res. 2015;2015:352934.","journal-title":"J Immunol Res"},{"key":"7175_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12865-016-0158-8","volume":"17","author":"E Shen","year":"2016","unstructured":"Shen E, Wang M, Xie H, Zou R, Lin Q, Lai L, et al. Existence of Th22 in children and evaluation of IL-22+ CD4+ T, Th17, and other T-cell effector subsets from healthy children compared to adults. BMC Immunol. 2016;17:20.","journal-title":"BMC Immunol"},{"key":"7175_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1179\/000349802125002211","volume":"96","author":"AM Musa","year":"2002","unstructured":"Musa AM, Khalil EA, Raheem MA, Zijlstra EE, Ibrahim ME, Elhassan IM, et al. The natural history of Sudanese postkala-azar dermal leishmaniasis: clinical, immunological and prognostic features. Ann Trop Med Parasitol. 2002;96:765\u201372.","journal-title":"Ann Trop Med Parasitol"},{"key":"7175_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.chom.2017.12.002","volume":"23","author":"R Dey","year":"2018","unstructured":"Dey R, Joshi AB, Oliveira F, Pereira L, Guimar\u00e3es-Costa AB, Serafim TD, et al. Gut microbes egested during bites of infected sand flies augment severity of leishmaniasis via inflammasome-derived IL-1\u03b2. Cell Host Microbe. 2018;23:134-43.e6.","journal-title":"Cell Host Microbe"},{"key":"7175_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008666","volume":"14","author":"TB Campolina","year":"2020","unstructured":"Campolina TB, Villegas LEM, Monteiro CC, Pimenta PFP, Secundino NFC. Tripartite interactions: Leishmania, microbiota and Lutzomyia longipalpis. PLoS Negl Trop Dis. 2020;14:e0008666. https:\/\/doi.org\/10.1371\/journal.pntd.0008666.","journal-title":"PLoS Negl Trop Dis"},{"key":"7175_CR19","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1128\/JCM.00966-12","volume":"50","author":"S Ghosh","year":"2012","unstructured":"Ghosh S, Banerjee P, Sarkar A, Datta S, Chatterjee M. Coinfection of Leptomonas seymouri and Leishmania donovani in Indian leishmaniasis. J Clin Microbiol. 2012;50:2774\u20138.","journal-title":"J Clin Microbiol"},{"key":"7175_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005060","volume":"10","author":"S Das","year":"2016","unstructured":"Das S, Mandal R, Rabidas VN, Verma N, Pandey K, Ghosh AK, et al. Chronic arsenic exposure and risk of post kala-azar dermal leishmaniasis development in India: a retrospective cohort study. PLoS Negl Trop Dis. 2016;10:e0005060. https:\/\/doi.org\/10.1371\/journal.pntd.0005060.","journal-title":"PLoS Negl Trop Dis"},{"key":"7175_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00439-020-02130-w","volume":"139","author":"JM Blackwell","year":"2020","unstructured":"Blackwell JM, Fakiola M, Castellucci LC. Human genetics of Leishmania infections. Hum Genet. 2020;139:813\u20139.","journal-title":"Hum Genet"},{"key":"7175_CR22","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S2666-5247(20)30166-X","volume":"2","author":"OP Singh","year":"2021","unstructured":"Singh OP, Tiwary P, Kushwaha AK, Singh SK, Singh DK, Lawyer P, et al. Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study. Lancet Microbe. 2021;2:e23\u201331. https:\/\/doi.org\/10.1016\/S2666-5247(20)30166-X.","journal-title":"Lancet Microbe"},{"key":"7175_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.actatropica.2017.03.006","volume":"171","author":"P Jambulingam","year":"2017","unstructured":"Jambulingam P, Pradeep Kumar N, Nandakumar S, Paily KP, Srinivasan R. Domestic dogs as reservoir hosts for Leishmania donovani in the southernmost Western Ghats in India. Acta Trop. 2017;171:64\u20137. https:\/\/doi.org\/10.1016\/j.actatropica.2017.03.006.","journal-title":"Acta Trop"},{"key":"7175_CR24","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1093\/infdis\/jiae156","volume":"229","author":"OP Singh","year":"2024","unstructured":"Singh OP, Chaubey R, Kushwaha AK, Fay MP, Sacks D, Sundar S. Visceral leishmaniasis-human immunodeficiency virus-coinfected patients are highly infectious to sandflies in an endemic area in India. J Infect Dis. 2024;229:1909\u201312. https:\/\/doi.org\/10.1093\/infdis\/jiae156.","journal-title":"J Infect Dis"},{"key":"7175_CR25","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/exd.14760","volume":"32","author":"R Sengupta","year":"2023","unstructured":"Sengupta R, Mitra S, Dighal A, Moulik S, Chaudhuri SJ, Das NK, et al. Does immune dysregulation contribute toward development of hypopigmentation in Indian post kala-azar dermal leishmaniasis? Exp Dermatol. 2023;32:740\u201351. https:\/\/doi.org\/10.1111\/exd.14760.","journal-title":"Exp Dermatol"},{"key":"7175_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012655","volume":"18","author":"M Roy","year":"2024","unstructured":"Roy M, Sengupta R, Chakraborty BC, Chatterjee U, Stebut EV, Kaye PM, et al. Role of neutrophils in the pathogenesis of post kala-azar dermal leishmaniasis (PKDL). PLoS Negl Trop Dis. 2024;18:e0012655. https:\/\/doi.org\/10.1371\/journal.pntd.0012655.","journal-title":"PLoS Negl Trop Dis"},{"key":"7175_CR27","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s44197-024-00270-0","volume":"14","author":"A Torres","year":"2024","unstructured":"Torres A, Younis BM, Alamin M, Tesema S, Bernardo L, Solana JC, et al. Differences in the cellular immune response during and after treatment of Sudanese patients with postkala-azar dermal leishmaniasis, and possible implications for outcome. J Epidemiol Glob Health. 2024;14:1167\u201379. https:\/\/doi.org\/10.1007\/s44197-024-00270-0.","journal-title":"J Epidemiol Glob Health"},{"key":"7175_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011780","volume":"17","author":"BM Younis","year":"2023","unstructured":"Younis BM, Mudawi Musa A, Monnerat S, Abdelrahim Saeed M, Awad Gasim Khalil E, Elbashir Ahmed A, et al. Safety and efficacy of paromomycin\/miltefosine\/liposomal amphotericin B combinations for the treatment of postkala-azar dermal leishmaniasis in Sudan: a phase II, open label, randomized, parallel arm study. PLoS Negl Trop Dis. 2023;17:e0011780.","journal-title":"PLoS Negl Trop Dis"},{"key":"7175_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01492","volume":"8","author":"R Kumar","year":"2017","unstructured":"Kumar R, Chauhan SB, Ng SS, Sundar S, Engwerda CR. Immune checkpoint targets for host-directed therapy to prevent and treat leishmaniasis. Front Immunol. 2017;8:1492. https:\/\/doi.org\/10.3389\/fimmu.2017.01492.","journal-title":"Front Immunol"},{"key":"7175_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17154-z","volume":"11","author":"WW Zhang","year":"2020","unstructured":"Zhang WW, Karmakar S, Gannavaram S, Dey R, Lypaczewski P, Ismail N, et al. A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing. Nat Commun. 2020;11:3461. https:\/\/doi.org\/10.1038\/s41467-020-17154-z.","journal-title":"Nat Commun"},{"key":"7175_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.trstmh.2007.08.006","volume":"102","author":"AM Musa","year":"2008","unstructured":"Musa AM, Khalil EA, Mahgoub FA, Elgawi SH, Modabber F, Elkadaru AE, et al. Immunochemotherapy of persistent postkala-azar dermal leishmaniasis: a novel approach to treatment. Trans R Soc Trop Med Hyg. 2008;102:58\u201363.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"7175_CR32","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1016\/j.ymthe.2021.03.020","volume":"29","author":"BM Younis","year":"2021","unstructured":"Younis BM, Osman M, Khalil EAG, Santoro F, Furini S, Wiggins R, et al. Safety and immunogenicity of ChAd63-KH vaccine in postkala-azar dermal leishmaniasis patients in Sudan. Mol Ther. 2021;29:2366\u201377. https:\/\/doi.org\/10.1016\/j.ymthe.2021.03.020.","journal-title":"Mol Ther"},{"key":"7175_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2024.101310","volume":"32","author":"BM Younis","year":"2024","unstructured":"Younis BM, Wiggins R, Khalil EAG, Osman M, Santoro F, Sonnati C, et al. A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis. Mol Ther. 2024;32:101310. https:\/\/doi.org\/10.1016\/j.omtm.2024.101310.","journal-title":"Mol Ther"},{"key":"7175_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009531","volume":"15","author":"J Carstens-Kass","year":"2021","unstructured":"Carstens-Kass J, Paulini K, Lypaczewski P, Matlashewski G. A review of the leishmanin skin test: a neglected test for a neglected disease. PLoS Negl Trop Dis. 2021;15:e0009531. https:\/\/doi.org\/10.1371\/journal.pntd.0009531.","journal-title":"PLoS Negl Trop Dis"},{"key":"7175_CR35","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","volume":"356","author":"EA Khalil","year":"2000","unstructured":"Khalil EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, et al. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomized, double-blind, BCG-controlled trial in Sudan. Lancet. 2000;356:1565\u20139.","journal-title":"Lancet"},{"key":"7175_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4269\/ajtmh.22-0586","volume":"110","author":"P Saini","year":"2023","unstructured":"Saini P, Fathima PA, Aiswarya RS, Ajithlal PM, Rajesh KR, Simi SM, et al. Cutaneous and visceral leishmaniasis caused by the same zymodeme of Leishmania donovani in Kerala, India. Am J Trop Med Hyg. 2023;110:59\u201363.","journal-title":"Am J Trop Med Hyg"},{"key":"7175_CR37","doi-asserted-by":"publisher","first-page":"298","DOI":"10.25259\/IJDVL_415_2022","volume":"89","author":"S Roy","year":"2023","unstructured":"Roy S, Roy M, Nath S, Chaudhuri SJ, Ghosh MK, Mukherjee S, et al. Role of molecular approaches to distinguish post kala-azar dermal leishmaniasis from leprosy: a case study. Indian J Dermatol Venereol Leprol. 2023;89:298\u2013300. https:\/\/doi.org\/10.25259\/IJDVL_415_2022.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"7175_CR38","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4103\/ijd.IJD_307_19","volume":"65","author":"V Ramesh","year":"2020","unstructured":"Ramesh V, Ramam M. Histopathology of post kala-azar dermal leishmaniasis. Indian J Dermatol. 2020;65:461\u20134.","journal-title":"Indian J Dermatol"},{"key":"7175_CR39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijpddr.2019.08.005","volume":"11","author":"R Sengupta","year":"2019","unstructured":"Sengupta R, Mukherjee S, Moulik S, Mitra S, Chaudhuri SJ, Das NK, et al. In situ immune profile of polymorphic vs. macular Indian Post Kala-azar dermal leishmaniasis. Int J Parasitol Drugs Drug Resist. 2019;11:166\u201376.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7175_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012393","volume":"18","author":"S Ranasinghe","year":"2024","unstructured":"Ranasinghe S, Senarathne S, Somaratne V, Lacey CJN, Jayakody S, Wickramasinghe A, et al. Development of a core outcome measure instrument; \u201cLeishCOM_LCL\u201d, for localised cutaneous leishmaniasis. PLoS Negl Trop Dis. 2024;18:e0012393.","journal-title":"PLoS Negl Trop Dis"},{"key":"7175_CR41","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ijpara.2017.02.005","volume":"47","author":"OD Kirstein","year":"2017","unstructured":"Kirstein OD, Abbasi I, Horwitz BZ, Skrip L, Hailu A, Jaffe C, et al. Minimally invasive microbiopsies: a novel sampling method for identifying asymptomatic, potentially infectious carriers of Leishmania donovani. Int J Parasitol. 2017;47:609\u201316. https:\/\/doi.org\/10.1016\/j.ijpara.2017.02.005.","journal-title":"Int J Parasitol"},{"key":"7175_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.645121","volume":"11","author":"K Cloots","year":"2021","unstructured":"Cloots K, Singh OP, Singh AK, Van der Auwera G, Kumar P, Gedda MR, et al. Assessing L. donovani skin parasite load: a proof of concept study of a microbiopsy device in an Indian setting. Front Cell Infect Microbiol. 2021;11:645121.","journal-title":"Front Cell Infect Microbiol"},{"key":"7175_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa364","volume":"7","author":"G Churiso","year":"2020","unstructured":"Churiso G, van Henten S, Cnops L, Pollmann J, Melkamu R, Lemma M, et al. Minimally invasive microbiopsies as an improved sampling method for the diagnosis of cutaneous leishmaniasis. Open Forum Infect Dis. 2020;7:ofaa364.","journal-title":"Open Forum Infect Dis"},{"key":"7175_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae113","volume":"11","author":"S van Henten","year":"2024","unstructured":"van Henten S, Kassa M, Fikre H, Melkamu R, Mekonnen T, Dessie D, et al. Evaluation of less invasive sampling tools for the diagnosis of cutaneous leishmaniasis. Open Forum Infect Dis. 2024;11:ofae113.","journal-title":"Open Forum Infect Dis"},{"key":"7175_CR45","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/infdis\/jiae497","volume":"231","author":"M Azam","year":"2025","unstructured":"Azam M, Das VNR, Ramesh V, Gupta T, Topno RK, Dixit KK, et al. Rapid antigen detection test for diagnosis of postkala-azar dermal leishmaniasis: application of CL detect rapid test for active case detection in the endemic area. J Infect Dis. 2025;231:993\u20137. https:\/\/doi.org\/10.1093\/infdis\/jiae497.","journal-title":"J Infect Dis"},{"key":"7175_CR46","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00132-21","volume":"59","author":"KK Dixit","year":"2021","unstructured":"Dixit KK, Ramesh V, Upadhyay S, Singh AK, Singh OP, Sundar S, et al. Utility of blood as the clinical specimen for the molecular diagnosis of post-kala-azar dermal leishmaniasis. J Clin Microbiol. 2021;59:e0013221.","journal-title":"J Clin Microbiol"},{"key":"7175_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011231","volume":"17","author":"M Roy","year":"2023","unstructured":"Roy M, Ceruti A, Kobialka RM, Roy S, Sarkar D, Wahed AAE, et al. Evaluation of recombinase polymerase amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis. PLoS Negl Trop Dis. 2023;17:e0011231. https:\/\/doi.org\/10.1371\/journal.pntd.0011231.","journal-title":"PLoS Negl Trop Dis"},{"key":"7175_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-021-04961-6","volume":"14","author":"MAA Khan","year":"2021","unstructured":"Khan MAA, Faisal K, Chowdhury R, Nath R, Ghosh P, Ghosh D, et al. Evaluation of molecular assays to detect Leishmania donovani in Phlebotomus argentipes fed on postkala-azar dermal leishmaniasis patients. Parasit Vectors. 2021;14:465.","journal-title":"Parasit Vectors"},{"key":"7175_CR49","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s15010-024-02179-z","volume":"52","author":"RM Kobialka","year":"2024","unstructured":"Kobialka RM, Ceruti A, Roy M, Roy S, Chowdhury R, Ghosh P, et al. Portable smartphone-based molecular test for rapid detection of Leishmania spp. Infection. 2024;52:1315\u201324.","journal-title":"Infection"},{"key":"7175_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04026-23","volume":"12","author":"S Ghosh","year":"2024","unstructured":"Ghosh S, Verma A, Kumar D, Deep DK, Ramesh V, Salotra P, et al. Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era. Microbiol Spectr. 2024;12:e0402623.","journal-title":"Microbiol Spectr"},{"key":"7175_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.25259\/IJDVL_410_19","volume":"87","author":"K Pandey","year":"2021","unstructured":"Pandey K, Pal B, Siddiqui NA, Lal CS, Ali V, Bimal S, et al. A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis. Indian J Dermatol Venereol Leprol. 2021;87:34\u201341. https:\/\/doi.org\/10.25259\/IJDVL_410_19.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"7175_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012242","volume":"18","author":"S Sundar","year":"2024","unstructured":"Sundar S, Pandey K, Mondal D, Madhukar M, Kamal Topno R, Kumar A, et al. A phase II, noncomparative randomized trial of two treatments involving liposomal amphotericin B and miltefosine for postkala-azar dermal leishmaniasis in India and Bangladesh. PLoS Negl Trop Dis. 2024;18:e0012242. https:\/\/doi.org\/10.1371\/journal.pntd.0012242.","journal-title":"PLoS Negl Trop Dis"},{"key":"7175_CR53","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4269\/ajtmh.19-0370","volume":"102","author":"EE Zijlstra","year":"2020","unstructured":"Zijlstra EE, Liberton N, Musa AM, Te Slaa S, Wolff J. Three-dimensional optical scanning in postkala-azar dermal leishmaniasis (PKDL). Am J Trop Med Hyg. 2020;102:286\u20138. https:\/\/doi.org\/10.4269\/ajtmh.19-0370.","journal-title":"Am J Trop Med Hyg"},{"key":"7175_CR54","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41590-023-01569-z","volume":"24","author":"V Aggarwal","year":"2023","unstructured":"Aggarwal V, Workman CJ, Vignali DAA. LAG-3 as the third checkpoint inhibitor. Nat Immunol. 2023;24:1415\u201322.","journal-title":"Nat Immunol"}],"updated-by":[{"DOI":"10.1186\/s13071-026-07422-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000}}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-07175-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-07175-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-07175-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T18:39:35Z","timestamp":1779993575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13071-025-07175-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7175"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-07175-2","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13071-026-07422-0","URL":"https:\/\/doi.org\/10.1186\/s13071-026-07422-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}